Chemours (CC) Revenue (2014 - 2026)

Chemours' Revenue history runs 13 years deep, the most recent figure standing at $1.4 billion for Q1 2026.

• In Q1 2026, Revenue rose 0.95% year-over-year to $1.4 billion; the TTM figure through Mar 2026 stood at $5.8 billion (up 0.54% YoY), while the FY2025 annual figure was $5.8 billion, changed 0.45% from the prior year.
• Revenue was $1.4 billion for Q1 2026 at Chemours, up from $1.3 billion in the prior quarter.
• In the past five years, Revenue ranged from a high of $1.9 billion in Q2 2022 to a low of $1.3 billion in Q4 2025.
• Historically, Revenue has averaged $1.5 billion across 5 years, with a median of $1.5 billion in 2023.
• The sharpest annual moves came in 2022 and 2023: Revenue rose 22.84% in 2022, then retreated 15.53% in 2023.
• A 5-year view of Revenue shows it stood at $1.3 billion in 2022, then climbed by 2.24% to $1.4 billion in 2023, then retreated by 0.66% to $1.4 billion in 2024, then retreated by 2.21% to $1.3 billion in 2025, then gained by 3.91% to $1.4 billion in 2026.
• The last three Revenue figures came in at $1.4 billion (Q1 2026), $1.3 billion (Q4 2025), and $1.5 billion (Q3 2025), per Business Quant data.